Systemic Juvenile Idiopathic Arthritis Therapeutics Assessment. Major key companies such as Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, ...

Medically reviewed by Anita C. Chandrasekaran, MDMedically reviewed by Anita C. Chandrasekaran, MD Juvenile idiopathic arthritis (JIA) is arthritis that affects children and whose cause is unknown ...

Your child has systemic juvenile idiopathic arthritis. Systemic JIA is one of the seven subtypes of arthritis that are included under the umbrella term of juvenile idiopathic -- meaning having an ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...

About 30% of all children with juvenile idiopathic arthritis have this type. It usually affects the small joints, like those in the hands and feet, but it can sometimes involve the large joints.

Juvenile idiopathic arthritis affects children under age 16. Learn about common symptoms such as joint problems, fatigue, loss of appetite, and more.

Systemic-onset juvenile idiopathic arthritis (SJIA) is rare but it can be a devastating disease that responds poorly to therapy. Case series have suggested that the interleukin-1 receptor ...

1 Appraisal Committee’s preliminary recommendations. 1.1 Tocilizumab is not recommended for the treatment of systemic juvenile idiopathic arthritis in children and young people aged 2 to 17 years and ...

Treatment with canakinumab resulted in rapid, sustained improvements in active systemic juvenile idiopathic arthritis, regardless of whether the patient had a fever at initiation, according to ...

Systemic juvenile idiopathic arthritis (SJIA) isn’t common: It affects about 10 to 15 percent of all people with JIA. It happens when the body’s immune system goes into overdrive and attacks ...

The FDA has approved Actemra (tocilizumab; Genentech), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA), or Still's ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...